-
Torrent Pharma receives USFDA approval for generic Nexium
Torrent Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for rabeprazole sodium tablets, a generic version of Nexium.
-
Torrent Pharmaceuticals Q3 net profit rises 32% to Rs 934 crore
Torrent Pharmaceuticals reported a 32% increase in its net profit for the third quarter ended December 31, 2022, to Rs 934 crore.
-
Torrent Pharma gets DCGI nod for Covid drug Molnupiravir
Torrent Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) to manufacture and market Molnupiravir, an oral antiviral drug for the treatment of mild to moderate COVID-19 in adults.
-
Torrent Pharma acquires Curatio Healthcare for Rs 2,000 crore
Torrent Pharmaceuticals has acquired Curatio Healthcare for Rs 2,000 crore in an all-cash deal. Curatio Healthcare is a leading player in the Indian branded generics market with a strong presence in the chronic segment.
-
Torrent Pharma launches generic version of Merck's Keytruda
Torrent Pharmaceuticals has launched the generic version of Merck's blockbuster cancer drug Keytruda (pembrolizumab) in India. The drug is used to treat a variety of cancers, including melanoma, lung cancer, and bladder cancer.
-
Torrent Pharma reports strong Q3 results
Torrent Pharmaceuticals has reported strong results for the third quarter of fiscal 2023. The company's revenue grew by 18% to Rs 2,273 crore, while its net profit grew by 22% to Rs 426 crore.
-
Torrent Pharma gets USFDA nod for antidepressant
The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Desvenlafaxine Extended-Release Tablets, 50 mg, 100 mg, and 150 mg.
-
Torrent Pharma's anti-allergic drug gets USFDA nod
The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Fexofenadine Hydrochloride Tablets, 180 mg.
-
Torrent Pharma gets USFDA nod for diabetes drug
The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Glimepiride Tablets, 1 mg, 2 mg, and 4 mg.